GLP‐1 receptor agonists penetrate the BBB and activate GLP‐1 receptors in the brain.54, 64 However, no T2DM patients developed depression among those using a GLP‐1 receptor agonist in the present study. The gene discussed is GLP1R; the disease is major depressive disorder.